These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6352667)

  • 21. [The prevention of arrhythmias in acute myocardial infarct. Use of ajmaline in continuous phleboclysis and of oral disopyramide].
    Selvini A; Ferrari ML; Roda L; Gironi G
    Minerva Med; 1969 May; 60(35):1706-10. PubMed ID: 5790015
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets.
    Nauta IL; van de Calseyde J; Hertzberger DP
    Curr Med Res Opin; 1983; 8(8):582-93. PubMed ID: 6653136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
    Bassan R; Miqueloti P; de Souza MA; Luz FS
    Arq Bras Cardiol; 1982 Nov; 39(5):355-7. PubMed ID: 7186390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Arrhythmia in patients with aspirin-treated myocardial infarction].
    Banasiak W; Telichowski C; Metner E; Góral J; Petruk J; Zebrowski J
    Wiad Lek; 1988 Nov; 41(21):1409-14. PubMed ID: 3074579
    [No Abstract]   [Full Text] [Related]  

  • 25. Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
    Kumana CR; Rambihar VS; Willis K; Gupta RN; Tanser PH; Cairns JA; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):529-37. PubMed ID: 6753888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical observations on effects of disopyramide on arrhythmias].
    Hu BL; Tao SQ; Liu LS; Chen ZJ; Lu ZL; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():60-2. PubMed ID: 6459881
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-dysrhythmic treatment in acute myocardial infarction.
    Lancet; 1979 Jan; 1(8109):193-4. PubMed ID: 84210
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M
    Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion from intravenous to oral slow-release disopyramide in acute myocardial infarction.
    Zannad F; Royer-Morrot MJ; Zakari I; Sadoul N; Royer RJ
    Fundam Clin Pharmacol; 1987; 1(3):219-24. PubMed ID: 3428841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group.
    Postgrad Med J; 1984 Feb; 60(700):98-107. PubMed ID: 6369290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disopyramide in myocardial infarction.
    Lancet; 1977 Dec; 2(8049):1185-6. PubMed ID: 73103
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metoprolol in acute myocardial infarction--clinical effect and tolerance].
    Dłuzniewski M; Jurgiel R; Budaj A
    Kardiol Pol; 1985; 28(11):683-9. PubMed ID: 3915041
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect on mortality of metoprolol in acute myocardial infarction. A randomized double-blind trial (author's transl)].
    Hjalmarson A; Elmfeldt D; Herlitz J; Holmberg S; Málek I; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wihelmsson C
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):32-45. PubMed ID: 6799780
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Effect of nicotinic acid analogue on plasma free fatty acids and ventricular arrhythmias after myocardial infarction.
    Rowe MJ; Oliver MF
    Br Heart J; 1974 Oct; 36(10):1037. PubMed ID: 4611459
    [No Abstract]   [Full Text] [Related]  

  • 37. [Palpitin in disorders of cardiac rhythm].
    Zadionchenko VS; Vladimirova LM; Smirnov VK; Ivashchuk AG; Terekhova TM; Troshina EV; Vladimirov PV; Sliuniastikov MA
    Sov Med; 1989; (10):62-5. PubMed ID: 2694383
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardioprotective and anti-arrhythmia omega 3 fatty acids. Protection from sudden cardiac death].
    MMW Fortschr Med; 2002 Sep; 144(37):54. PubMed ID: 12380341
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; Przegaliński J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.